Project Details
Projekt Print View

Cancer cell subpopulation and host crosstalk during metastasis of pancreatic ductal adenocarcinoma (PDAC)

Subject Area General and Visceral Surgery
Term from 2019 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 429807806
 
Final Report Year 2022

Final Report Abstract

In this project, we have investigated pancreatic cancer cell-T cell interactions and focused on distinct cancer cell-intrinsic mechanisms in modulating their response to T cell attack. For that, we have established a 3D cancer spheroid/tumor-educated (ed)T cell co-culture system and successfully isolated edT cell-resistant cancer cell subpopulations. We revealed their differential gene expression and signaling pathways compared to sensitive cells with a combination of transcriptomic analyses, as well as cytometric and immunohistochemistry techniques. A decreased CXCL12/CXCR4 signaling showed to contribute to edT cell-resistance in PDAC cells. Adding back CXCL12 to resistant cells in edT cell-culture improved effector T cell functionality and re-sensitized them to T cell attack. This new methodological approach facilitates to dissect mechanisms of pancreatic cancer cell sensitivity and resistance to T cell-mediated cytotoxicity in an unprecedented way and has the potential to identify new druggable targets in cancer cell – T cell crosstalk that could be applied for T cell-based immunotherapies or combinatorial treatment regimen together with targeted anticancer agents in patients with pancreatic ductal adenocarcinoma (PDAC). The biggest surprise of this project was the observation that T cell-mediated killing rates are highly distinct between different pancreatic cancer cell population derived from the same tumor. This suggests that differential cancer cell-autonomous mechanisms contribute to regulate resistance and sensitivity to T cell attack. The paradigm that pancreatic cancer is generally “cold”, meaning impenetrable for T cells and thus primarily resistant to immunotherapy does not hold true. Targeting distinct resistance mechanisms of cancer cell subpopulations might improve T cell response and synergize with standard of care treatment options.

Publications

  • Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture. J Vis Exp. 2020; (160)
    Lin YN, Nasir A, Camacho S, Berry DL, Schmidt MO, Pearson GW et al.
    (See online at https://doi.org/10.3791/61392)
  • (2022). Biological, biomechanical and translational aspects of cell movement in health and disease. Book chapter 6: Cell migration. Michael Schnoor, Sean Sun, Lei-Miao Yin. Elsevier Academic Press
    Lin YN, Wellstein A
    (See online at https://doi.org/10.1016/B978-0-323-90195-6.00011-5)
  • Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity. OncoImmunology 2022; 11: 2027136
    Lin YN, Schmidt MO, Sharif GM, Vietsch EE, Kiliti AJ, Barefoot ME, Riegel AT and Wellstein A
    (See online at https://doi.org/10.1080/2162402x.2022.2027136)
 
 

Additional Information

Textvergrößerung und Kontrastanpassung